The Investing News Network (INN) had the opportunity to tour the vibrant Las Vegas cannabis market last Thursday (November 15) through visits to a production facility and a dispensary.

Nevada legalized adult-use cannabis in 2017, which has led to the burst of a new scene with tourism cannabis consumption booming. Several operators have also set up shop across the state.

According to a projection from Statista, Nevada will reach US$433 million in sales value for the marijuana market in 2019, with that figure increasing to US$587 million by 2020.

In a research note to investors Neal Gilmer, analyst with Haywood Securities, wrote adult-use sales had exceeded initial expectations reaching US$424.9 million in the first year of sales.

“This strong start to the program in Nevada suggests that the market is well positioned to continue to capture market share from the residents and more importantly for operators, the tourists,” Gilmer said.

The tour, organized by Grit Capital and KCSA Strategic Communications, took a select group of investors across a scenic route of the current landscape in the Las Vegas marijuana market.

The first stop was the GreenMart NV production facility from MPX Bioceuticals (CSE:MPX).

MPX is currently undergoing a merger of sorts with iAnthus Capital Holdings (CSE:IAN), in which iAnthus will obtain all the US assets from MPX.

The facility is predominantly focussed on recreational products due to a new found interest in MPX’s dried flower.

Cannabis grown inside the GreenMart NV facility from MPX Bioceuticals. Photo By Bryan Mc Govern.

As told to the groups, the facility will be expanded sometime soon basically replicating the existing production cycle. This process would likely take a year once approved.

The facility consists of different growing rooms in which the plants are cycled through.

MPX is also working with novel products such as candy infused with cannabis elements and other extracts.

Candy-like cannabis product developed at the CannMart NV facility. Photo by Bryan Mc Govern.

On the way to the next stop, investors were treated to a presentation from High Hampton Holdings’ (CSE:HC) director and interim CEO Christian Scovenna.

As part of Scovenna’s pitch presentation, the executive announced the new full time CEO for the company. Gary Latham, who previously spent time with Mojave Jane in California, will step up as the new leading executive.

Investors were then taken to “The Source,” a dispensary from Green Growth Brands (CSE:GGB), previously known as Xanthic Biopharma, located in the western area of Las Vegas.

Peter Horvath, CEO of GGB, told the investor audience he wants his retail experience not to compete with those of existing cannabis retailers in the US.

The executive broke down the idea of not reaching for nationally-known brands due to, according to him, the dislike from millennials for these brands.

Instead, Horvath said he wants city-specific diversified emotion-driven brands that appeal to consumers in each market.

“We’re not comparing ourselves with Green Thumb Industries (CSE:GTII) and MedMen (CSE:MMEN), we’re comparing ourselves to Lululemon (NASDAQ:LULU) and Glossier,” Horvath said.

GTI and MedMen have both added to the rush of multi-state operators of cannabis assets in the US market raising capital in Canada.

GTI has operations in Nevada, Florida, Illinois, Ohio, Pennsylvania, New York, Massachusetts while MedMen serves the California, Nevada and New York markets and will add assets in Florida.

Julia Fulton, investor relations officer for GGB, told INN the company’s expansion plans for retail aren’t locked to just the US; she said there’s a possibility for the company to apply for a license in the upcoming Ontario market.

The provincial government of Ontario will open a free retail market in April of 2019 in which licensed producers (LPs) will be restricted to one store.

The last stop of the tour for investors was a quick look at a distribution facility from KushCo Holdings (OTCQB:KSHB), a cannabis packaging, supply and accessory operator aiding the US industry.

Nick Kovacevich, CEO of KushCo, greeted investors into its Las Vegas offices but explained the actual eye candy of a facility was in the company’s California operations.

When discussing the company, Kovacevich explained KushCo is excited about a new venture with the sale of [particular] gas tanks designed for processing and extraction.

The executive was forward with the investor group and said the company’s biggest challenges moving forward is making sure to meet the demand of clients’ requests in terms of packaging.

Before the end of the tour, and as the last stop David Rendimonti, president and CEO of LiveWell Canada (TSXV:LVWL), gave a talk on the importance and potential for the cannabidiol (CBD) hemp market.

LiveWell plans to position itself at the center of the nascent subsector of the cannabis industry: health and wellness products.

The company, which debuted on the TSX Venture Exchange (TSXV) in June, reported C$20.1 million raised as of June 30.

“Over the next 12 months, LiveWell will continue to make waves as we develop and prepare our suite of products, in addition to delivering wholesale CBD to the market,” Rendimonti said.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: High Hampton Holdings and Xanthic Biopharma are clients of the Investing News Network. This article is not paid-for content.

The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in contributed article. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less